Pharmion
AcquiredBoulder, United States · Founded 1999 · $105.0M raised
- Headquarters
- Boulder, Colorado
- Employees
- 201–500
- Founded
- 1999
- Business Model
- B2B
- Website
- pharmion.com
- Total Funding
- $105.0M
- Last Round
- $40.0M Series BNov 2002
- Rounds
- 3
- Acquired by
- CelgeneMar 2008 · $2.9B
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Pharmion Corporation was a specialty pharmaceutical company headquartered in Boulder, Colorado, focused on acquiring and commercializing innovative medicines for hematology and oncology, particularly for European and other international markets. Founded in 1999, Pharmion commercialized drugs including azacitidine (Vidaza) and thalidomide for hematologic malignancies, and was acquired by Celgene Corporation in 2008.
Summary
Pharmion is a Biotech company based in Boulder, United States, founded in 1999. It has raised $105.0M in total across 3 rounds, most recently a $40.0M Series B round in Nov 2002. Investors include Celgene Corporation, New Enterprise Associates and Phase4 Partners.
Funding & Exit History
Mar 2008
Sign up to see all 4 events
Funding: Seed through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pharmion"><img src="https://indexed.vc/api/badge/company/pharmion" alt="Pharmion on Indexed.vc" width="260" height="76" /></a>